Tweenvest Stocks

Flerie AB (publ) (OM: FLERIE)

Health Care · Pharmaceuticals · SE

Skr15.10

-0.66% today · -57.2% 1Y

Flerie AB (publ) (OM: FLERIE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $131.79M and employs 2 people.

Over the last twelve months the share price has lost 57.2%, trading between 15.10 and 36.92.

Tweenvest scores Flerie AB (publ) across four factors: quality 61/100, value 53/100. Its strongest factor is quality.

FLERIE price history

Not enough price history to draw a chart yet.

Key figures

Market cap
$131.79M
Revenue (TTM)
$-577.79K
P/E
—
EPS
-9.68
Dividend yield
—
Beta (5Y)
-0.33
52-week high
Skr36.92
52-week low
Skr15.10
Avg volume (3M)
—
Shares outstanding
86.70M
Employees
2
Next earnings
—

About Flerie AB (publ)

Flerie AB (publ) functions as a venture capital entity, concentrating its investments on nascent businesses. The firm actively seeks to fund biotechnology and pharmaceutical companies dedicated to advancing drug discovery and development, or producing innovative tools and applications aimed at addressing pressing global health concerns. Geographically, their investment scope includes Europe, the United States, and Israel. Founded in 2011, Flerie AB (publ) is headquartered in Stockholm, Sweden, and also operates a branch office in London, United Kingdom.

ISIN
SE0022447348
Founded
2011
Listed since
Jun 11, 2024
Exchange
OMX Nordic Exchange Stockholm
Currency
SEK
CompanyMarket capPriceDay
The ACME Laboratories Ltd.DSE: ACMELAB$133.67MTk77.80-0.51%
Samil Pharmaceutical Co.,LtdKOSE: A000520$132.73M₩8,350.00-2.91%
Bharat Parenterals LimitedBSE: 541096$132.61MRs1,862.25+8.43%
Chong Kun Dang Holdings Corp.KOSE: A001630$131.91M₩37,250.00-0.27%
Daewon Pharmaceutical Co., Ltd.KOSE: A003220$130.57M₩8,190.00+3.80%
CellBion Co., Ltd.KOSDAQ: A308430$130.36M₩13,580.00-4.10%
BIOBIJOU Co.,Ltd.KOSDAQ: A489460$129.60M₩11,810.00+2.43%
MPH Health Care AGDB: 93M1$128.48M€26.80+1.13%

Browse every Pharmaceuticals company →

Figures last refreshed Oct 11, 2026.